Transformation of rifamycin S into rifamycins B and L. A revision of the current biosynthetic hypothesis.
O Ghisalba, R Roos, T Schupp, J Nüesch
Index: J. Antibiot. 35(1) , 74-80, (1982)
Full Text: HTML
Abstract
The transformation of rifamycin S into rifamycins B and L was reinvestigated in order to establish more detailed pathways. Our results exclude rifamycin O as a common progenitor in the biosyntheses of rifamycins B and L. Rifamycins B and L are formed from rifamycin S (SV) by different pathways using different C3-precursors for the biosynthesis of their glycolic acid moieties. A thiamine-dependent enzyme (decarboxylase) seems to be involved in the transformation reaction.
Related Compounds
Related Articles:
2014-04-01
[Nat. Prod. Rep. 31(4) , 504-13, (2014)]
2011-10-15
[Bioorg. Med. Chem. Lett. 21 , 6094-9, (2011)]
2011-08-17
[J. Am. Chem. Soc. 133(32) , 12795-800, (2011)]
2012-04-01
[Microbiology 158(Pt 4) , 1117-26, (2012)]
2002-08-01
[Indian J. Exp. Biol. 40(8) , 930-3, (2002)]